Levy 1974.

Study characteristics
Methods	Trial design: randomised, double‐blind, within‐participant study Trial registration number: not reported Country: USA Outpatient or hospital: outpatient Date trial conducted: not reported Duration of trial participation: 21 days Inclusion criteria: comparable, symmetrical areas of steroid‐responsive dermatoses Exclusion criteria: not reported Additional design details: this study also included 25 patients with psoriasis and with miscellaneous corticosteroid responsive dermatoses.
Participants	Total number randomised: 44 sides treated (22 to apply the intervention and 22 to apply the comparator) Age: 10 to 67 years Sex: male n = 12, female n = 10 Ethnicity: not reported Duration of eczema: 4 months to 60 years Severity of eczema, body site: not reported Number of withdrawals: 7 patients withdrew but this was not separated by skin condition. Notes: none
Interventions	Run‐in details: not reported Intervention: fluocinonide 0.05% FAPG used twice daily for 21 days · Concurrent treatment: not reported · Other key information: none Comparator: vehicle FAPG used twice daily for 21 days · Concurrent treatment: not reported · Other key information: none Concurrent treatments received alongside both intervention and comparator: not reported Notes: FAPG is a specially designed base that combines the physical properties of a cream and a gel.
Outcomes	· Improvement evaluation based mainly on the appearance of the lesions in the test areas. The categories of scoring were: very good or excellent; moderate improvement; and no improvement or worse.
Notes	Funding source: not reported Declarations of interest: not declared Original language of publication: English Other: none